These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 13499836)

  • 1. Treatment of haemochromatosis by energetic phlebotomy; one patient's response to the letting of 55 litres of blood in 11 months.
    CROSBY WH
    Br J Haematol; 1958 Jan; 4(1):82-8. PubMed ID: 13499836
    [No Abstract]   [Full Text] [Related]  

  • 2. Phlebotomy for haemochromatosis; effect of removing 52 pints of blood in sixteen months.
    HOUSTON JC
    Lancet; 1953 Apr; 1(6764):766-8. PubMed ID: 13036160
    [No Abstract]   [Full Text] [Related]  

  • 3. Iron saturation of ferritin in the course of phlebotomy treatment in patients with haemochromatosis.
    ten Kate J; Marell K; Huizinga R; Kreeftenberg H; van Deursen C
    Clin Chem Lab Med; 1999 Aug; 37(8):827-30. PubMed ID: 10536932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of haemochromatosis by repeated venesection.
    DAVEY DA; FOXELL AW; KEMP TA
    Br Med J; 1954 Dec; 2(4903):1511-4. PubMed ID: 13209163
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diagnosis and treatment of primary hemochromatosis].
    Swinkels DW; Marx JJ
    Ned Tijdschr Geneeskd; 1999 Jul; 143(27):1404-8. PubMed ID: 10422553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased insulin secretory capacity but decreased insulin sensitivity after correction of iron overload by phlebotomy in hereditary haemochromatosis.
    Abraham D; Rogers J; Gault P; Kushner JP; McClain DA
    Diabetologia; 2006 Nov; 49(11):2546-51. PubMed ID: 17019598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood donation by healthy individuals with haemochromatosis.
    Blacklock HA; Dewse M; Bollard C; Hudson P; Barnhill D; Jackson S
    N Z Med J; 2000 Mar; 113(1105):77-8. PubMed ID: 10855583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Who needs a therapeutic phlebotomy?
    Antle EA
    Clin J Oncol Nurs; 2010 Dec; 14(6):694-6. PubMed ID: 21112847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Patient's record. Treatment of hemochromatosis].
    Rev Prat; 2006 Dec; 56(19):2148. PubMed ID: 17416053
    [No Abstract]   [Full Text] [Related]  

  • 10. [Erythrocytapheresis for hereditary haemochromatosis].
    Rombout-Sestrienkova E; van Deursen CT; Janssen MC; van Kraaij MG; de Leeuw PW; Koek GH
    Ned Tijdschr Geneeskd; 2012; 156(26):A4745. PubMed ID: 22759710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demanding pure motives for donation: the moral acceptability of blood donations by haemochromatosis patients.
    Pennings G
    J Med Ethics; 2005 Feb; 31(2):69-72. PubMed ID: 15681668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does phlebotomy in people with haemochromatosis become history?
    Swinkels DW; Matlung HL
    Lancet Gastroenterol Hepatol; 2023 Dec; 8(12):1063-1064. PubMed ID: 37863079
    [No Abstract]   [Full Text] [Related]  

  • 13. Haemochromatosis.
    Adams PC; Barton JC
    Lancet; 2007 Dec; 370(9602):1855-60. PubMed ID: 18061062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hemochromatosis by massive venesection; report of a case treated by removal of forty liters of blood in twenty-eight months.
    MYERSON RM; CARROLL IN
    AMA Arch Intern Med; 1955 Feb; 95(2):349-53. PubMed ID: 13227659
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduced exercise capacity in genetic haemochromatosis.
    Davidsen ES; Liseth K; Omvik P; Hervig T; Gerdts E
    Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):470-5. PubMed ID: 17568251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The treatment of idiopathic hemochromatosis by repeated phlebotomy.
    WARTHIN TA; PETERSON EW; BARR JH
    Ann Intern Med; 1953 May; 38(5):1066-9. PubMed ID: 13041047
    [No Abstract]   [Full Text] [Related]  

  • 17. Hereditary haemochromatosis: patient support and education.
    Sheahan O; O'Connell E
    Nurs Stand; 2009 Sep 23-29; 24(3):49-56. PubMed ID: 19856645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hereditary hemochromatosis: molecular diagnosis and effect of treatment].
    Szczeklik W; Dropiński J; Dziedzina S; Szułdrzyński K; Biesiada G; Mach T; Sanak M
    Pol Arch Med Wewn; 2004 May; 111(5):593-6. PubMed ID: 15508811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular diastolic function in patients with treated haemochromatosis.
    Davidsen ES; Omvik P; Hervig T; Gerdts E
    Scand Cardiovasc J; 2009 Feb; 43(1):32-8. PubMed ID: 18609062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is HFE haemochromatosis?
    Marjot T; Collier J; Ryan JD
    Br J Hosp Med (Lond); 2016 Jun; 77(6):C91-5. PubMed ID: 27269766
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.